Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature. Issue 9 (29th April 2020) - Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Kanapuru, Bindu; Gormley, Nicole; Waldron, Peter E.